Log in
(Ad)
A devastating technical glitch could crush the next generation of wireless technology before it even launches. With trillions of dollars and millions of jobs at stake, one company with the "5G fix" could put as much as $234,770 in your pocket this year. But Wall Street vultures are circling... you'll need to move quickly or risk missing this $5 bargain.

CVE:HEM - Hemostemix Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range
C$0.01
MA: C$0.01▼
C$0.02
52-Week Range N/A
Volume50,000 shs
Average Volume211,611 shs
Market CapitalizationC$4.51 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Hemostemix Inc., a clinical-stage biotechnology company, develops, manufactures, and commercializes blood-derived cell therapies for medical conditions in Canada. It develops cell therapy products from the patient's own blood, a relatively non-invasive source of therapeutic cells. The company's lead product is ACP-01, which is in Phase II clinical trial for the treatment of critical limb ischemia. It is also developing various types of cells products, such as synergetic cell precursors, myocardial cell precursors, and neural cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.

Industry, Sector and Symbol

Stock Exchange CVE
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolCVE:HEM
Previous Symbol
CUSIPN/A
CIKN/A
Webhttp://www.hemostemix.com/
Phone+1-403-3409207

Debt

Debt-to-Equity RatioN/A
Current Ratio0.09
Quick Ratio0.09

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash Flow15.00
Book ValueC($0.01) per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares300,899,008
Market CapC$4.51 million
Next Earnings DateN/A
OptionableNot Optionable

Receive HEM News and Ratings via Email

Sign-up to receive the latest news and ratings for HEM and its competitors with MarketBeat's FREE daily newsletter.

TSXV:HEM Rates by TradingView

(Ad)


I call it my "Dividend Map", and I'll show you exactly where to find the safest companies that pay the highest yields. (HINT: Texas has 6 of these companies sending huge payouts that average 77%!). I'm willing to send you my Map... but only if you

Hemostemix (CVE:HEM) Frequently Asked Questions

What is Hemostemix's stock symbol?

Hemostemix trades on the Canadian Venture Exchange (CVE) under the ticker symbol "HEM."

Has Hemostemix been receiving favorable news coverage?

Media stories about HEM stock have been trending neutral on Sunday, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Hemostemix earned a news impact score of 0.2 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Hemostemix.

Who are some of Hemostemix's key competitors?

What other stocks do shareholders of Hemostemix own?

Who are Hemostemix's key executives?

Hemostemix's management team includes the folowing people:
  • Mr. Kyle Makofka, Chief Exec. Officer
  • Ms. Kristin Gulka CPA, CA, Chief Financial Officer
  • Ms. Eilat Bain, Director of Operations
  • Dr. Alan J. Jacobs, Chief Medical Consultant

How do I buy shares of Hemostemix?

Shares of HEM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How big of a company is Hemostemix?

Hemostemix has a market capitalization of C$0.00. View Additional Information About Hemostemix.

What is Hemostemix's official website?

The official website for Hemostemix is http://www.hemostemix.com/.

How can I contact Hemostemix?

Hemostemix's mailing address is Bay 1, PO Box 10, BLACKFALDS, AB T0M 0J0, Canada. The biotechnology company can be reached via phone at +1-403-3409207.


MarketBeat Community Rating for Hemostemix (CVE HEM)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  47 (Vote Underperform)
Total Votes:  105
MarketBeat's community ratings are surveys of what our community members think about Hemostemix and other stocks. Vote "Outperform" if you believe HEM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HEM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/19/2020 by MarketBeat.com Staff

Featured Article: How to build a Fibonacci channel
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel